HFS
PLSE icon

Horizon Financial Services’s Pulse Biosciences PLSE Stock Holding History

Horizon Financial Services’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-400
Closed -$9K – 153
2021
Q3 		$9K Buy
+400
New +$8.61K 0.01% 110

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Horizon Financial Services's PLSE Position: Q4 2021 in Review

Horizon Financial Services sold out of Pulse Biosciences (PLSE) in Q4 2021, closing a stake of 400 shares — an estimated $9K sold.

Horizon Financial Services first reported a position in PLSE in Q3 2021 and held it in 1 quarter. The position peaked at $9K in Q3 2021. 48 funds tracked by Wall St. Rank hold PLSE as of Q4 2021.

  • Horizon Financial Services reported no remaining Pulse Biosciences position as of Q4 2021 after selling out during the quarter.
  • Horizon Financial Services sold 400 Pulse Biosciences shares in Q4 2021, an estimated $9K.
  • Horizon Financial Services first reported a position in Pulse Biosciences in Q3 2021 and held it in 1 quarter.
  • Horizon Financial Services's Pulse Biosciences position peaked at $9K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2021.

Based on Horizon Financial Services's 13F filing for Q4 2021, filed 31 Jan 2022.